Result Update. Nilkamal Limited CMP: INR1675 TP: INR2,184(+30%) Quarterly Standalone Performance (INR mn)

Similar documents
Domestic air passengers increase 16.9% in November

CMP: INR270 TP: INR335(+24%) Buy Takes price hike disguised as evacuation charges

CMP: INR80 TP: INR106(+32%) Buy MIB approves merger of VD2H

Lupin. CMP: INR861 TP: INR1,000(+16%) Buy Goa and Indore plant receives Warning Letter

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

Domestic shortage driving e-auction prices

CMP: INR688 TP: INR1,050(+53%) Buy Opportunity in adversity?

Focus on premium segment and bridging product gaps

CMP: INR759 TP: INR910 (+20%) Upgrade to Buy Ad recovery on the cards

Appoints CapGemini s Salil Parekh as CEO and MD. Potential positives

Expect capacity-led rerating; maintain Buy

Idea Cellular. CMP: INR105 TP: INR120 (+15%) Buy Board approves raising INR32.5b via preferential issue

CMP: INR64 TP: INR65 (+1%) Neutral Going retail

CMP: INR145 TP: INR196 (+33%) Buy Expect orders to spurt in FY19

CMP: INR678 TP: INR780 (+15%) Buy

Banking on innovation to drive growth

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

CMP: INR228 TP: INR275 (+20%) Buy Firm utilization continues

CMP: INR734 TP: INR764 (+4%) Neutral

CMP: INR656 TP: INR780(+19%) Buy Solutions in sight

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block

CMP: INR110 TP: INR130(+17%) Buy Cement division set for a better 2HFY18

CMP: INR532 TP: INR675(+27%) Buy

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

CMP: INR475 TP: INR609 (+28%) Buy

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Financial integrity intact; FDA resolution the key

CMP: INR400 TP: INR470(+18%) Buy

CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

CMP: INR840 TP: INR941 (+12%) Neutral TRAI boost to RJio; increasing target price

Hardick Bora

CMP: INR272 TP: INR361(+33%) Buy Production ramp-up encouraging

Voltas-Beko product line to be launched in 2HCY18. We recently met management of Voltas (VOLT). Key takeaways:

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Bata India. CMP: INR415 TP: INR483 (+16%) Upgrade to Buy Aggressive, focused strategy to drive growth. Upgrading to Buy

CMP: INR576 TP: INR590 (+2%) Neutral Advancement and PMLA affect 2QFY18 sales

CMP: INR2,623 TP: INR2,875 (+10%) Neutral

HOLD. Margins to improve from Q2 AMBUJA CEMENTS. Target Price: Rs 232. Other highlights

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Change EPS. (Rs) FY

Hindustan Zinc. 30 April QFY18 Results Update Sector: Metals. Estimate change TP change Rating change

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

Ashok Leyland. CMP: INR145 TP: INR179 (+23%) Buy Positive CV demand outlook for FY19 and FY20

Sanjay Jain Pavas Pethia

CMP: INR113 TP: INR180(+59%) Buy Some pricing pressure, but fundamentals are strong

CPCB-2: Important long-term driver

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

Castrol India. CMP: INR407 TP: INR474 (+16%) Neutral

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

Niket Shah

Idea Cellular. CMP: INR59 TP: INR75(+27%) Buy Near-term headwinds persist

CMP: INR949 TP: INR1,140 (+20%) Buy

Larsen & Toubro. CMP: INR1,400 TP: INR1,690 (+21%) Divests E&A business to Schneider Electric for INR140b

To voluntarily stop supplies to US

BUY MULTI COMMODITY EXCHANGE OF INDIA. Strong Q2; All eyes on option volumes. Target Price: Rs 1,280. Concall highlights

CMP: INR388 TP: INR465(+20%) Buy

A win-win combination

Ashok Leyland. CMP: INR126 TP: INR159 (+26%) Buy M&HCV axle load proposed to be increased up to 25% Is it precursor to stricter norms on overloading?

Sohail Halai Alpesh Mehta

He is BTech from IIT Bombay ( , Aeronautical Engineering) and MS from Cornell University ( , Mechanical Engineering).

CMP: INR293 TP: INR300(+2%) Neutral To sell hosted datacenter services business

CMP: INR587 TP: INR705 (+21%) Upgrade to Buy

CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification

BUY MULTI COMMODITY EXCHANGE OF INDIA. Demonetization,GST uncertainty impact Q4. Target Price: Rs 1,397. Concall highlights

Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some profit-making

ABB India to remain a key sourcing hub

Hold Target Price: Rs 574

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades

CMP: INR158 TP: INR195 (+24%) Buy Lowering crude oil price estimates

CMP: INR826 TP: INR810 (-2%) Neutral

Titan Industries. CMP: INR222 TP: INR220 Neutral

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Amber Enterprises India Ltd

JSW Energy. CMP: INR59 TP: INR84 (+42%) Buy Valuations heavily discounting merchant capacities

CMP: INR540 TP: INR650 (+20%) BUY

Idea Cellular. CMP: INR159 TP: INR200 Buy

Cross service charges at INR m/quarter

Mr Nilesh Gupta MD. Lupin. Prepping for next wave of growth. Takeaways from CEO track

PVR Ltd. CMP: INR685 TP: INR750 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy

April 2017: Off-take growth remains strong

Visaka Industries Ltd

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Torrent Pharmaceuticals

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Jinesh Gandhi Chirag Jain

CMP: INR120 TP: INR140(+16%) Buy

Cummins India Ltd Bloomberg Code: KKC IN

Fineotex Chemical Ltd

CMP: INR945 TP: INR1,196 (+26%) Buy

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

CMP: INR907 TP: INR1,150(+24%) Buy

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

CMP: INR164 TP: INR198(+21%) Buy Project commissioning augurs well for capitalization

CMP: INR350 TP: INR375 Downgrade to Neutral

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

CMP: INR952 TP: INR1,300(+37%) Buy Multi-faceted reforms have only just begun

Transcription:

Result Update 18th May 18 4QFY18 Result Update I Industry: Plastic Products Nilkamal Limited BSE SENSEX S&P CNX 34,848,596 CMP: INR1675 TP: INR2,184(+30%) Buy Inline performance for 4QFY18. Better volume growth in plastics division and ramp up of mattresses segment to be the key growth driver. Stock Info Bloomberg NILK IN Equity Shares (m) 14.9 52-Week Range (INR) 2134 / 1491 1/6/12 m Rel. Per (%) -8 / 0.3 / -35 M.Cap. (INR b) 25.0 M.Cap. (USD b) 0.38 Avg Turnover, INR m 143 Free float (%) 36 *Data as on 18th May, 18 ^ relative to BSE sensex Financials Snapshot (INR bn) Y/E Mar 18P 19E E Net Sales 21.2 23.8 27.1 EBITDA 2.4 2.8 3.3 PAT 1.2 1.4 1.6 EPS (INR) 82.7 94.2 9.2 Gr. (%) 0.8 13.8 16.0 BV/Sh (INR) 569 645 732 P/E (x).3 17.8 15.4 P/BV (x) 3.0 2.6 2.3 EV/E (x).8 9.3 8.0 Div. PO (%) 17.7 19.1.6 RoE (%) 15.5 15.5 15.9 RoCE (%) 14.2 14.3 14.5 Shareholding pattern (%) As On Mar-18 Dec-17 Sept-17 Promoter 64.1 64.1 64.1 MFs 11.1.9 9.6 FPIs 3.4 3.4 3.6 Others 21.4 21.6 22.7 Investors are advised to refer through disclosures made at the end of the Research Report. Performance in line: For 4QFY18, Nilkamal's revenue grew 12.1% YoY to INR5.9bn, largely driven by volume growth in plastic business (up ~8% YoY). EBITDA growth was up 11.7% YoY. Benefit of softer raw material prices was offset by increased other expenses leading to flat EBITDA margins at 11.0%. However, increased interest cost and higher tax expenses (as the tax exemptions for company s Jammu unit is over and company now falls under full tax bracket) resulted in PAT growth of 5.0% YoY. FY19/ to be better, driven by plastics and mattresses segment: Nilkamal is a leading player in moulded plastic furniture and material handling products. Visibility of capex revival and strong economic growth is expected to drive volume growth across both the divisions. Newly launched mattresses segment is also picking up strongly and we expect the momentum to continue on the back of shift from unorganized to organized and increasing income levels. We expect revenue/ebitda/pat CAGR of 13%/17%/15% over FY18-E largely driven by plastics business and newly added mattresses division. Revised capex guidance bodes well for the company: The company has increased its capex guidance for FY19 to INR1,500 mn from INR1,000 mn earlier. The increased capex is mainly due to a new foam manufacturing plant (capex of INR350mn) which is a step towards backward integration of its newly launched mattress business. Major capex would be towards increasing manufacturing capacity of injection and rota-moulding process, manufacturing of metal and MDF furniture, introduction of new products in its plastics business etc. Valuation: Nilkamal has steady growth, healthy balance sheet and stable RoEs. At CMP of INR1,680 it trades at 15.4x FYE and we believe that with improving product mix, better operational efficiency and market share shift to organized players, Nilkamal could command higher valuations. We continue to maintain our Buy rating on the stock with a target price of INR2,184 (giving a upside of 30%) valuing the company at x FYE EPS of INR9. Quarterly Standalone Performance (INR mn) Y/E December 4QFY18 4QFY17 YoY (%) 3QFY18 QoQ (%) Revenue 5,961 5,319 12.1 5,228 14.0 EBITDA 653 585 11.7 662-1.4 EBITDA Margin % 11.0 11.0-3bps 12.7-171bps Interest 34 27 27.3 37-8.0 Depreciation 112 116-2.8 125-9.9 PBT 526 460 14.2 504 4.4 Tax 188 138 35.8 173 8.6 PAT 338 322 5.0 331 2.2 PAT Margin % 5.7 6.1-38bps 6.3-65bps Siddhartha Khemka siddhartha.khemka@motilaloswal.com Alpesh Thacker Alpesh.thacker@motilaloswal.com

Story in Charts Exhibit 1: Revenue growth trend 700 600 500 400 300 0 0 - (2.2) 16.5 6.9 5.8 (0.8) 5.5 12.1 469 496 532 488 465 523 596 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Revenue (INR bn) Growth YoY % 15 5 0-5 Exhibit 2: EBITDA margins improving 70 60 50 40 30-11.0 9.9 11.0 9.1 12.3 12.7 11.0 51 49 58 45 57 66 65 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 EBITDA (INR bn) EBITDA Margin % 14 12 8 6 4 2 0 Exhibit 3: Adj. PAT growth trending up 40 30 - (16.9) 7.3 14.1 18.2 18.9 2.2 (26.9) 26 28 32 24 28 33 34 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Adjusted PAT (INR bn) Growth YoY % 30 0 - - -30 Exhibit 4: Segmental revenue mix (4QFY18) 8% 92% Plastics Lifestyle Risk and concerns Volatility in raw material prices could impact profitability: Nilkamal s raw material is closely linked to crude. Any sharp volatility in crude oil price could impact the company's margins in case of its inability to pass on the input cost inflation to its customers. Inability to ramp-up new businesses in near future: The company also entered the mattress business in 11 which is yet to contribute meaningfully and has now entered into the building material segment (bubble guard). The overall financials could be impacted in case the company is unable to significantly ramp-up these businesses in near future. 18 May 18 2

Company Profile Company description Exhibit 5: 1-year stock performance rebased to 0 Nilkamal is an industry leader in the moulded furniture and material handling products with diversified product portfolio catering to different industries and a diversified base of customers including household customers, industrial customers and retail buyers. It also has presence in the retail business of lifestyle furniture, furnishings and accessories under its brand '@home' & Nilkamal Mattresses. The company has two major business verticals viz; 1) Plastic division and 2) Lifestyle Furniture, furnishings and accessories division. In FY18, Plastics division contributed ~91% to the total revenues while the retail division ('@home') contributed ~9% to the revenue. 1 95 70 May-17 Aug-17 Nov-17 Feb-18 May-18 Nilkamal S&P BSE 500 Source: Bloomberg Exhibit 6: Top holders as on Mar-18 Holder % Holding DSP Blackrock Smallcap Fund 3.8 Mirae Asset Emerging Bluechip Fund 2.3 Hdfc Small Cap Fund 2.8 Tata Equity P/E Fund 1.4 Dolly Khanna 1.5 Exhibit 7: Top management Mr. Vamanrai V. Parekh Mr. Sharad V. Parekh Mr. Hiten V. Parekh Mr. Manish V. Parekh Mr. Nayan S. Parekh Designation Chairman Managing Director Joint MD and Promoter President and ED (Furniture) President and ED (Material Handling) Exhibit 8: Directors Ms. Hiroo Mirchandani Mr. K. R. Ramamoorthy Mr. K. Venkataramanan Mr. Mahendra V. Doshi Mr. Mufazzal Federal Mr. S. K. Palekar Mr. Hiten V. Parekh Mr. Manish V. Parekh Mr. Nayan S. Parekh Mr. Sharad V. Parekh Mr. Vamanrai V. Parekh Exhibit 9: Auditors Type B S R & Co. LLP Statutory Vora & Associates Statutory Pratik M. Shah Secretarial Auditor B. F. Modi and Associates Cost Auditors 18 May 18 3

Financials and valuations Consolidated - Income Statement (INR Million) Y/E March FY14 FY15 FY16 FY17 FY18P FY19E FYE Net Sales 17,418 18,946 19,265,240 21,240 23,787 27,140 Change (%) 8.8 1.7 5.1 4.9 12.0 14.1 EBITDA 1,571 1,536 2,300 2,317 2,394 2,807 3,257 Margin (%) 9.0 8.1 11.9 11.4 11.3 11.8 12.0 Depreciation 522 574 550 505 505 619 727 EBIT 1,049 962 1,750 1,811 1,890 2,187 2,530 Int. and Finance Charges 425 299 182 117 125 163 160 Other Income 36 46 33 33 37 39 39 Extraordinary Items 0 0 0 0 0 0 0 PBT 659 708 1,601 1,728 1,801 2,064 2,408 Tax 183 196 516 536 630 721 842 Tax Rate (%) 27.8 27.6 32.2 31.0 35.0 35.0 35.0 Min. Int. & Assoc. Share 5 8-55 -34-63 -63-63 Reported PAT 470 505 1,141 1,225 1,235 1,405 1,630 Adjusted PAT 470 505 1,141 1,225 1,235 1,405 1,630 Change (%) - 7.3 126.0 7.4 0.8 13.8 16.0 Margin (%) 2.7 2.7 5.9 6.1 5.8 5.9 6.0 Consolidated - Balance Sheet (INR Million) Y/E March FY14 FY15 FY16 FY17 FY18P FY19E FYE Share Capital 149 149 149 149 149 149 149 Reserves 4,718 5,181 6,126 7,270 8,337 9,473,767 Net Worth 4,868 5,331 6,275 7,419 8,486 9,622,916 Minority Interest 54 62 72 72 72 76 80 Debt 2,709 1,692 832 826 932 1,232 1,232 Deferred Tax 250 162 3 65 130 130 130 Total Capital Employed 7,880 7,250 7,283 8,386 9,619 11,060 12,357 Gross Fixed Assets 7,735 7,694 3,265 3,702 4,940 5,927 6,827 Less: Acc. Dep n. 4,161 4,694 538 994 1,499 2,118 2,845 Net Fixed Assets 3,573 3,000 2,728 2,707 3,440 3,809 3,982 Capital WIP 22 12 45 3 88 300 0 Investments 18 325 435 416 463 452 446 Current Assets 6,799 6,285 6,769 7,488 8,490 9,355 11,132 Inventory 3,158 2,825 3,046 3,360 3,794 4,137 4,898 Debtors 2,357 2,369 2,691 3,0 3,401 3,809 4,614 Cash and Bank Balance 256 147 159 141 4 238 271 Loans and Advances 1,029 944 874 977 1,091 1,171 1,349 Curr. Liability & Provisions 2,532 2,373 2,694 2,546 2,862 2,856 3,302 Current Liabilities 1,897 1,768 1,966 1,727 2,111 2,019 2,323 Other Long Term Liab. & Provs. 635 604 728 818 751 836 980 Net Current Assets 4,267 3,913 4,075 4,943 5,628 6,499 7,830 Appl. of Funds 7,880 7,250 7,283 8,386 9,619 11,060 12,357 18 May 18 4

Ratios Y/E March FY14 FY15 FY16 FY17 FY18P FY19E FYE Basic (INR) EPS 31.5 33.8 76.4 82.1 82.7 94.2 9.2 Cash EPS 66.5 72.3 113.3 116.0 116.6 135.7 157.9 BV/Share 326.2 357.2 4.5 497.2 568.7 644.8 731.5 DPS 4.0 4.5 7.0 11.0 13.0 16.0.0 Payout (%) 14.7 15.5.3 15.1 17.7 19.1.6 Valuation (x) P/E 53.1 49.5 21.9.4.2 17.8 15.3 Cash P/E 25.2 23.2 14.8 14.4 14.4 12.3.6 P/BV 5.1 4.7 4.0 3.4 2.9 2.6 2.3 EV/Sales 1.6 1.4 1.3 1.3 1.2 1.1 1.0 EV/EBITDA 17.5 17.3 11.2 11.1.7 9.3 8.0 Dividend Yield (%) 0.2 0.3 0.4 0.7 0.8 1.0 1.2 FCF per share 86.3 91.8 94.9 18.5.9 7.7 32.5 Return Ratios (%) RoE 9.7 9.9 19.7 17.9 15.5 15.5 15.9 RoCE.3.0 17.1 16.6 14.2 14.3 14.5 Working Capital Ratios Asset Turnover (x) 2.2 2.6 2.6 2.4 2.2 2.2 2.2 Inventory (Days) 66 54 58 61 65 63 66 Debtor (Days) 49 46 51 54 58 58 62 Creditor (Days) 21 18 21 29 24 24 Leverage Ratio (x) Net Debt/Equity 0.5 0.2 0.0 0.0 0.0 0.1 0.0 Consolidated - Cash Flow Statement (INR Million) Y/E March FY14 FY15 FY16 FY17 FY18P FY19E FYE Adjusted EBITDA 1,571 1,536 2,300 2,317 2,394 2,807 3,257 (Inc)/Dec in Wkg. Cap. 265 250-45 -660-558 -837-1,297 Tax Paid -143-238 -515-578 -630-721 -842 Other operating activities -11 6 5 9 111 67 67 CF from Operations 1,681 1,554 1,845 1,088 1,318 1,315 1,185 (Inc)/Dec in FA & CWIP -393-185 -430-812 -1,006-1,0-700 Free Cash Flow 1,288 1,369 1,416 276 312 115 485 (Pur)/Sale of Investments -71-21 -123 12-47 11 6 Others 77 52 139 4 37 39 39 CF from Investments -387-155 -414-696 -1,016-1,150-655 Inc/(Dec) in Net Worth 0 0 0 0 0 0 0 Inc/(Dec) in Debt -814-1,112-1,021-185 6 300 0 Interest Paid -434-328 -8-145 -125-163 -160 Dividend Paid -65-69 -191-79 -218-269 -336 Others 0 0 0 0 0 0 0 CF from Fin. Activity -1,312-1,508-1,419-409 -238-131 -496 Inc/Dec of Cash -18-9 12-18 63 34 34 Add: Opening Balance 274 256 147 159 141 4 238 Closing Balance 256 147 159 141 4 238 271 18 May 18 5

Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 14 (herein after referred to as the Regulations). Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company, the details in respect of which are available on www.motilaloswal.com. MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE) and Bombay Stock Exchange Limited (BSE), Multi Commodity Exchange of India Limited (MCX) and National Commodity & Derivatives Exchange Limited (NCDEX) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository Limited (NSDL) and is member of Association of Mutual Funds of India (AMFI) for distribution of financial products and Insurance Regulatory & Development Authority of India (IRDA) as Corporate Agent for insurance products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at http://onlinereports.motilaloswal.com/dormant/documents/associate%details.pdf MOSL, it's associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject company at the end of the month immediately preceding the date of publication of the Research Report. MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the associates of MOSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have received any compensation from the subject company in the past 12 months. In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have: a) managed or co-managed public offering of securities from subject company of this research report, b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report, c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report. d) Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report. MOSL and it's associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. Terms & Conditions: This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by virtue of their receiving this report. Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. Disclosure of Interest Statement Nilkamal Ltd. Analyst ownership of 1% or more securities No A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading desk of MOSL or its associates maintains arm's length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company for which Research Team have expressed their views. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL & its group companies to registration or licensing requirements within such jurisdictions. For Hong Kong: This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) "SFO". As per SEBI (Research Analyst Regulations) 14 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to "Professional Investors" as defined in Part I of Schedule 1 to SFO. Any investment or investment activity to which this document relates is only available to professional investor and will be engaged only with professional investors." Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction where their offer or sale is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are 18 May 18 6

not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Disclaimer: This report is intended for distribution to Retail Investors. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. This information is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval. MOSL, its associates, their directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 00. Compliance Officer: Neeraj Agarwal, Email Id: na@motilaloswal.com, Contact No.:022-382885. Registration details of group entities.: Motilal Oswal Securities Ltd. (MOSL): INZ000158836 (BSE/NSE/MCX/NCDEX); CDSL: IN-DP-16-15; NSDL: IN-DP-NSDL-152-00; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA0000070. IRDA Corporate Agent - CA0541. Motilal Oswal Asset Management Company Ltd. (MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth management solutions. *Motilal Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Insurance, Bond, NCDs and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real Estate Investment Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products 18 May 18 7